Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
86 hedge funds and large institutions have $59.9M invested in Enzo Biochem, Inc. in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 18 closing their positions.
333% more call options, than puts
Call options by funds: $78K | Put options by funds: $18K
5% less capital invested
Capital invested by funds: $62.9M → $59.9M (-$2.96M)
4% less funds holding
Funds holding: 90 → 86 (-4)
13% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 30
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.91M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.42M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.34M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$1.29M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$841K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$3.11M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.53M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$2.41M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.13M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$786K |
ENZ Hedge Fund Activity: Q2 2015 in Review
86 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2015, worth a combined $59.9M — down 4.7% from $62.9M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ENZ and 15 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 26 added.
The largest buyer was Wellington Management Group, adding an estimated $1.91M. The largest seller was THB Asset Management, exiting entirely with an estimated $3.11M sold.
- 86 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2015, down from 90 in Q1 2015.
- Funds reported $59.9M of Enzo Biochem, Inc. stock for Q2 2015, down 4.7% quarter-over-quarter.
- 15 funds opened new Enzo Biochem, Inc. positions in Q2 2015 and 18 closed out, a net change of -3 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2015 was Wellington Management Group, an estimated $1.91M added.
- The largest Enzo Biochem, Inc. seller in Q2 2015 was THB Asset Management, an estimated $3.11M sold.
Based on aggregated 13F filings for Q2 2015.